GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Solasia Pharma KK (TSE:4597) » Definitions » Debt-to-Asset

Solasia Pharma KK (TSE:4597) Debt-to-Asset : 0.03 (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Solasia Pharma KK Debt-to-Asset?

Solasia Pharma KK's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was 円33.0 Mil. Solasia Pharma KK's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was 円27.0 Mil. Solasia Pharma KK's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2023 was 円2,229.0 Mil. Solasia Pharma KK's debt to asset for the quarter that ended in Dec. 2023 was 0.03.


Solasia Pharma KK Debt-to-Asset Historical Data

The historical data trend for Solasia Pharma KK's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solasia Pharma KK Debt-to-Asset Chart

Solasia Pharma KK Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.18 0.03 0.01 0.03

Solasia Pharma KK Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.03 0.03 0.03 0.03

Competitive Comparison of Solasia Pharma KK's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Solasia Pharma KK's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Solasia Pharma KK's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Solasia Pharma KK's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Solasia Pharma KK's Debt-to-Asset falls into.



Solasia Pharma KK Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Solasia Pharma KK's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Solasia Pharma KK's Debt-to-Asset for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Solasia Pharma KK  (TSE:4597) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Solasia Pharma KK Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Solasia Pharma KK's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Solasia Pharma KK (TSE:4597) Business Description

Traded in Other Exchanges
Address
2-1-1 Shiba Park, 4th Floor, Sumitomo Real Estate Shiba Park Tower, Minato-ku, Tokyo, JPN, 105-0011
Solasia Pharma KK develops and distributes pharmaceuticals and medical devices relating to malignant tumors.

Solasia Pharma KK (TSE:4597) Headlines

No Headlines